Zepbound cost with insurance
Two prices, and your plan decides which one is yours. If it covers Zepbound, Lilly's savings card brings a fill down toward $25. If your employer bought a plan that leaves weight-loss drugs out, the card has nothing to reduce, and the price is what LillyDirect charges anyone paying cash.
How much is Zepbound with insurance?
With a plan that covers Zepbound, the Zepbound savings card brings a fill to as little as $25. It takes off at most $100 a month and $1,300 a year, so $25 is what you pay only when your plan's own copay is $125 or less; above that, you pay the difference. Lilly's terms tie the card to a plan that covers Zepbound, so an exclusion leaves the self-pay route rather than a smaller discount. Paying cash, Zepbound is $449 a month once titrated, read from its own published page on 2026-08-19.
What the card leaves you paying
“As little as $25 for up to a 3-month prescription” is the headline. The cap behind it decides whether that is your price: the card pays the part of your copay above $25, up to $100 a month, so the higher your plan places Zepbound on its formulary, the less of the headline you see.
| Your plan's copay for a month | The card pays | You pay |
|---|---|---|
| $50 | $25 | $25 |
| $125 | $100 | $25 |
| $250 | $100 | $150 |
| $500 | $100 | $400 |
Arithmetic on the card's published cap, not a quote: your plan's copay for Zepbound is on its formulary. The yearly ceiling of $1,300 is $100 across 13 fills, because the maker counts a month as 28 days.
The terms: The $25 needs a commercial plan that already covers the Zepbound single-dose pen. Without coverage the same card lets you pay as little as $499 for a 28-day fill of the single-dose pen, up to 13 fills a year, or for the KwikPen as little as $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg up. Lilly's terms exclude anyone in a state, federal or government-funded program, and the list is longer than Medicare and Medicaid: Medicare Part D, Medicare Advantage, Medigap, DoD, VA and TRICARE are all named in it.
Read from the Zepbound savings card page on 2026-09-05; the offer ends 2026-12-31. Run your own copay through the calculator →
Two uses, and a plan decides each one separately
Zepbound's label carries two indications: long-term weight reduction in adults with obesity, or with overweight and at least one weight-related condition; and moderate to severe obstructive sleep apnea in adults with obesity. An employer's exclusion is written against weight loss — a use, not a molecule — so the same pen prescribed for sleep apnea is judged on the plan's sleep-apnea criteria instead of being refused outright.
For sleep apnea the request rests on a sleep study. The trials behind that approval counted an apnea-hypopnea index of 15 to 29 events an hour as moderate and 30 or more as severe, in adults with a BMI of 30 or more. Those are the figures to have in the chart before the request goes in.
How many employers cover it for weight
- 16% of firms with 200 to 999 workers
- 30% of firms with 1,000 to 4,999 workers
- 43% of firms with 5,000 or more workers
Firms offering health benefits whose largest plan covers GLP-1s used primarily for weight loss, in 2025. Among the largest that is up from 28% a year earlier, and 34% of covering firms require a dietitian, case manager, therapist or lifestyle program first. 2025 Employer Health Benefits Survey: summary of findings, KFF.
Indications read from FDA prescribing information for ZEPBOUND, via DailyMed.
If your plan says no
Find out which refusal it is first. A prior-authorization denial means the plan covers Zepbound and says this request did not meet its criteria; that has a deadline and an appeal. An exclusion means the benefit was never bought, so no appeal reaches it, and the question is for whoever chose the plan.
A standard prior authorization has to be decided within 15 days of the request, extendable once by 15; an urgent one within 72 hours. You have at least 180 days from a denial to appeal inside the plan, then four months from the final denial to ask for independent external review, unless the plan is grandfathered. 29 CFR 2560.503-1; 45 CFR 147.136
What a Zepbound request has to show → At a denial, the appeal letter builder runs in your browser and sends nothing.
Every route, and what it costs
| Your situation | What you pay |
|---|---|
| A plan that covers it, with the card | As little as $25 for up to a 3-month prescription, within the caps above |
| The card's yearly ceiling reached | Your plan's copay in full, until the card resets |
| A plan that excludes it | Lilly's terms tie the card to a plan that covers Zepbound, so an exclusion leaves the self-pay route rather than a smaller discount. Self-pay: $449 a month once titrated |
| Medicare, Medicaid or TRICARE | The card is barred — federal anti-kickback rules. Your plan's own rules decide instead. |
Cash price checked 2026-08-19.
Your insurer, and the other routes
Zepbound with insurance, answered
- How much is Zepbound with insurance?
- With a plan that covers it, as little as $25 on the maker's card, which takes off at most $100 a month and $1,300 a year. A copay above $125 leaves you paying the difference — $400 becomes $300. If your plan does not cover Zepbound, the self-pay price is $449 a month once titrated.
- Is Zepbound covered by insurance?
- Only if your employer's plan includes weight-loss drugs, and most do not: in KFF's 2025 survey the plans covering GLP-1s for weight loss were those of 16% of firms with 200 to 999 workers, 30% of firms with 1,000 to 4,999 workers, 43% of firms with 5,000 or more workers. Prescribed for moderate to severe sleep apnea it is a different use, and a plan that excludes weight loss can still cover it for that.
- Does the Zepbound savings card work if my plan does not cover it?
- No. Lilly's terms require commercial coverage for Zepbound and exclude anyone in a government program — Medicare Part D, Medicare Advantage, Medigap, Medicaid, TRICARE, the VA and the DoD among them. Without coverage the comparison is LillyDirect's self-pay price, which is the same for the vial and the KwikPen.
- Should my prescriber submit Zepbound for sleep apnea instead of weight?
- Only if you have it. The indication on the request has to match a diagnosis in your chart, backed by the sleep study, and a plan that finds one without the other will deny it. Where it is genuinely your diagnosis, submitting under it is not a workaround: it is the use the label was approved for, and the weight exclusion does not reach it.